Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-02-18 Purchase | 2021-02-18 4:05 pm | Hepion Pharmaceuticals Inc. | HEPA | Cavan John T Chief Financial Officer | 10,000 | $2 | $20,000 | 14,800 (Direct) | View |
| 2020-11-25 Purchase | 2020-11-30 4:53 pm | Hepion Pharmaceuticals Inc. | HEPA | Cavan John T Chief Financial Officer | 4,500 | $1.62 | $7,290 | 4,800 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-05-18 Option Award | 2021-05-20 4:35 pm | N/A 2031-05-18 | Hepion Pharmaceuticals Inc. | HEPA | Cavan John T Chief Financial Officer | 1,200,000 | $0 | 1,581,060 (Direct) | View |
| 2020-08-19 Option Award | 2020-08-21 4:15 pm | N/A 2030-08-19 | Hepion Pharmaceuticals Inc. | HEPA | Cavan John T Chief Financial Officer | 160,000 | $0 | 381,060 (Direct) | View |
| 2020-04-03 Option Award | 2020-04-07 4:13 pm | N/A 2030-04-03 | Hepion Pharmaceuticals Inc. | HEPA | Cavan John T Chief Financial Officer | 215,000 | $0 | 221,059 (Direct) | View |